Newswise There is great interest among glaucoma patients, scientists and doctors alike, in discovering regenerative therapies for the optic nerve and translating them from the laboratory to the clinic and stem cell therapy is one of several promising approaches being studied.
Recently, we heard from a glaucoma patient who enrolled in a patient-funded trial in which the person paid $20,000 and received stem cell injections around one eye. Patient-funded trials are studies in which patients pay to participate. This approach was developed because clinical trials are expensive and funding from traditional sources (such as the NIH, pharmaceutical companies, or private foundations) is decreasing.
Although patient-funded research would appear superficially to provide an avenue for patients to obtain therapies under investigation, it is controversial for a number of reasons, both scientific and ethical. Scientific considerations are deeply concerning: the gold standard for evaluating an experimental treatment is a randomized clinical trial in which participants are randomly allocated to the experimental treatment group or a control group that may not receive any treatment (placebo-controlled study), or may receive standard, approved therapies. Usually, study patients and doctors are both unaware of who receives which treatment and this study design minimizes bias towards a particular treatment.
In contrast, patient-funded trials do not have a control group, since it is extremely unlikely that patients would pay when there is a possibility of not receiving the experimental treatment. A control group is very important to determine if an experimental treatment really has an effect and also to compare the efficacy and risks of the experimental treatment versus other treatments. Although it is common in an early, phase 1 trial to treat perhaps the first 3-12 patients in an open-label, non-randomized study, by phase 2 trials, a randomized, masked design is ideal.
Even more concerning are the ethical considerations. These include disparity in access to the treatment, and risk of exploitation of vulnerable patients who have exhausted all treatment options and may be willing to undergo an unproven treatment at any cost. In addition, a reported lack of proper oversight and monitoring for patient-funded trials implies the possibility that these may be thinly-veiled attempts to make money by the treating clinic or physician before proper FDA approval of new treatment methods.
Since a gold standard research study is not always feasible, decisions regarding the benefits and risks of a particular treatment may have to be made with the evidence at hand. Given these considerations, we consulted Dr. Jeffrey Goldberg regarding stem cell therapy for glaucoma. Dr. Goldberg is a leading expert in therapies to regenerate the optic nerve and is part of the Catalyst for Cure team. His laboratory is developing novel stem cell approaches for glaucoma, and working steadily towards a translational program to bring discoveries out of the laboratory and into human testing once safety and efficacy in pre-clinical models is established.
Q: Dr. Goldberg, how might stem cells be helpful for patients with glaucoma?
A: Stem cells may be helpful for patients with glaucoma in different ways. Stem cells can be turned into trabecular meshwork cells in the front of the eye and transplanted in such a way as to lower eye pressure. This is an interesting approach but is not fundamentally about vision restoration.
For protecting or restoring vision, we really need to talk about stem cells in the back of the eye, at the retina. There, stem cells may have two positive effects. First, early in the disease, they may protect retinal ganglion cells from degenerating providing a neuroprotective effect. Later in the disease when patients have lost considerable numbers of retinal ganglion cells and optic nerve axons, and have thereby lost considerable vision, stem cells may be useful to replace lost ganglion cells and restore the connections from the eye to the brain. This last approachregrowing optic nerve fibers back to the brainhas been the most challenging but its also the most exciting.
What is the current status of research on stem cell therapy for glaucoma?
Our laboratory and a number of other laboratories have made considerable progress on the two main fronts of bringing stem cell therapy to optic nerve restoration for glaucoma. First, we and others have discovered molecular pathways that can be used to coax stem cells to turn into neurons that look and act like real retinal ganglion cells. This will allow us to turn large numbers of stem cells into retinal ganglion cells for cell replacement therapy. Second, we are just beginning to make progress in transplanting retinal ganglion cells into the retina in pre-clinical models, to study their integration into the adult retina, how they respond to light and grow back down the optic nerve to the brain. Together these advances have brought us to an exciting moment in stem cell research for optic nerve restoration in glaucoma.
Are you aware of any studies in which stem cell therapy stabilized or reversed vision loss from glaucoma?
Stem cells have not yet been properly tested in patients with glaucoma to look for their ability to stabilize or reverse vision loss. The careful move from the laboratory to clinical testing is still ahead of us, although with the intellectual energy and resources ready to deploy, such proper testing may not be far off.
If your family member had vision loss from glaucoma, would you recommend stem cell therapy at this time?
I am often asked by my patients if they should sign up for a patient-funded trial for stem cells for glaucoma, and I am in the habit of counseling against this. I am not aware of any properly designed stem cell trials for glaucoma with well-tested cell therapies being moved to human testing at this time, but I do think these will come.
Are there any risks or complications reported with stem cell therapy for glaucoma?
Indeed the risks for undergoing stem cell injections in any trial could be significant. Risks of infection, inflammation, and more severe vision loss will always be present; we are publishing a paper about 3 patients in the U.S. who participated in a patient-funded trial and lost significant vision due to severe inflammation in their eyes called endophthalmitis. These 3 unfortunate patients point to the importance of a cell therapy first undergoing proper testing in pre-clinical models before moving to human testing. Then, with properly designed and sequenced trials, I believe cell therapies can be safely tested in the eye as with the rest of the body. Indeed there are a number of cell therapies for macular degeneration already in human testing with a reassuring safety record thus far.
What type of study would you design for evaluating stem cell therapy with glaucoma?
After demonstrating safety and efficacy of a cell therapy product in pre-clinical models, a small pilot study designed to assess for safety after injection in humans and analysis of the results should be the first step. After this, a move to a randomized trial with a control group and masked observers will be best to assess efficacy in phase 2 and eventually phase 3 trials.
Article by Sunita Radhakrishnan, MD, Jeffrey L. Goldberg, MD, PhD, and Andrew Iwach, MD.
For additional information on this topic, following are links to related articles from the American Academy of Ophthalmology:
Unregulated Stem Cell Treatments Can Be Dangerous [June 6, 2017]
American Academy of Ophthalmology Statement on Stem-Cell Therapy for Treating Eye Disease [March 20, 2017]
Unapproved stem cell treatment blinds 3 patients [March 17, 2017]
Stem Cell Therapy for Eye Disease: What You Need to Know [June 24, 2016]
Intraocular Stem Cell Therapy [June 2016]
- The global wound care market is growing at a CAGR of over 5% during the forecast period20182024 - Yahoo Finance - October 15th, 2019
- Saving rhinos with stem cells; $5.5 billion stem cell ballot measure readied - The San Diego Union-Tribune - October 12th, 2019
- BEYOND LOCAL: Expert recommends 'path of cautious optimism' about the future of stem cell treatment - ThoroldNews.com - October 12th, 2019
- Microbiome research needs a gut check - The Globe and Mail - October 12th, 2019
- BEYOND LOCAL: Expert recommends 'path of cautious optimism' about the future of stem cell treatment - GuelphToday - October 11th, 2019
- Biohack Your Way To Beauty And Health Using Your DNA And Stem Cells At These Wellness Retreats Around The World - Singapore Tatler - October 11th, 2019
- I donated my embryos years ago. Now I'm friends with the mom who received them - Yahoo Lifestyle - October 11th, 2019
- Man with at least 17 children sues fertility clinic for being 'incredibly irresponsible' with his sperm - Genetic Literacy Project - October 11th, 2019
- Senior, caregivers conference and expo coming Oct. 11 - The Daily Courier - October 9th, 2019
- Stem cell research is a good thing | Opinion - Chart - October 6th, 2019
- Regenerative medicine today: Are diabetes and vascular disease treatments ready for the clinic? - Science Magazine - October 5th, 2019
- Dr Naveen Pemmaraju Outlines the Symptoms of Myelofibrosis - AJMC.com Managed Markets Network - October 5th, 2019
- Businesses Sponsor Another Season Of Movies In The Park Square - Osprey Observer - October 5th, 2019
- Stem Cell Manufacturing | Research Report Overview By Top Key Players, Opportunities, Key Drivers, Application and Regional Outlook To 2027 -... - October 5th, 2019
- Sigilon Therapeutics approaches the clinic - Vantage - September 20th, 2019
- Research report explores the Animal Stem Cell Therapy Market - Zebvo - September 20th, 2019
- 'It feels amazing,' says Alabama man now first in the state to be free of sickle cell after gene therapy - Face2Face Africa - September 20th, 2019
- Michael Schumacher Is 'Conscious', Released From Paris Hospital After Experimental Treatment - International Business Times - September 20th, 2019
- Fighting for a cure: Tennis benefit to fund ALS research - Auburn Villager - September 20th, 2019
- Living With a Secondary Blood Cancer - Curetoday.com - September 20th, 2019
- Scientists Discover New Strategy That May Protect Against Hair-Loss During Cancer Treatments - Good News Network - September 20th, 2019
- Clinical trial of stem cell therapy for traumatic spinal ... - September 17th, 2019
- Autologous stem cell transplant - Type - Mayo Clinic - June 1st, 2019
- Stem cell therapy for hip | Mayo Clinic Connect - May 11th, 2019
- Next Generation Stem Cell - Professional medical clinic - April 7th, 2019
- N.Y. Attorney General Sues Manhattan Stem Cell Clinic ... - April 6th, 2019
- ThriveMD | Colorado's Experts in Stem Cells & Regenerative ... - March 29th, 2019
- Top Rated Stem Cell Therapy Clinic in Denver & Vail ... - March 16th, 2019
- South Florida Stem Cell Center | Regenerative Therapy Clinic - March 16th, 2019
- Mayo Clinic Q and A: Stem cell therapy for arthritis ... - March 7th, 2019
- COPD and stem cell treatment | Mayo Clinic Connect - March 7th, 2019
- GARM Stem Cell Clinic | Roatan - March 2nd, 2019
- Stem Cell Clinic Treatment Jupiter FL Alternative ... - March 1st, 2019
- Is This Stem-Cell Clinic Really Making Cancer Vaccines ... - February 12th, 2019
- Stem cells treatment clinic - Effective stem cell treatment - February 1st, 2019
- Vitality Healthcare - Home - January 28th, 2019
- About Us - U.S. Stem Cell Clinic - December 19th, 2018
- Brandon Stem Cell Clinic - December 19th, 2018
- Illinois Stem Cell Clinic - Illinois Stem Cell Clinic ... - October 5th, 2018
- Wisconsin Stem Cell Clinic - September 19th, 2018
- FDA Response - U.S. Stem Cell Clinic - June 29th, 2018
- World Stem Cell Clinic - For a better quality of life | WSCC - June 18th, 2018
- Stem Cell Clinic Palmetto - Stem Cell Therapy Greenwood ... - June 18th, 2018
- Top Stem Cell Therapy Clinic in Vail & Denver, Colorado ... - September 20th, 2017
- Stem Cell Therapy - American Regenerative Clinic, Stem ... - September 19th, 2017
- Zika kills brain cancer cells, may find use as therapy - The San Diego Union-Tribune - September 5th, 2017
- FDA Reaffirms Its Commitment to the Approval of Stem Cell Therapies Amidst Enforcement Actions Against ... - Lexology (registration) - September 5th, 2017
- US FDA steps up enforcement against unscrupulous stem cell firms - BioPharma-Reporter.com - September 3rd, 2017
- FDA Reaffirms Its Commitment to the Approval of Stem Cell Therapies Amidst Enforcement Actions Against ... - JD Supra (press release) - September 3rd, 2017
- Around the world - Bend Bulletin - August 29th, 2017
- Daily on Healthcare: Lack of bare counties doesn't solve Obamacare's problems - Washington Examiner - August 29th, 2017
- How a UCSF study could change the lives of babies in the womb and maybe help California's stem cell program in ... - San Francisco Business Times - August 25th, 2017
- Stem Cell Study for Dogs - MyWabashValley - August 23rd, 2017
- Joint Preservation vs. Replacement: What's Your Best Option? - Health Essentials from Cleveland Clinic (blog) - August 23rd, 2017
- Bio-inspired Materials Give Boost to Regenerative Medicine - Bioscience Technology - August 22nd, 2017
- Fraud Alert! Unproven Stem Cell Use Prompts International Call to Action - American Council on Science and Health - August 20th, 2017
- Friends come together for benefit concert for Joni Eickhoff - Grand Island Independent - August 16th, 2017
- 'Unexpected fountain of youth' found in cardiac stem cells, researcher says - FOX31 Denver - August 16th, 2017
- New Mayo Clinic facility aims to increase lungs available for transplant - First Coast News - August 10th, 2017
- Surrey teen rallies stem cell donors to help with 'desperate' need for South Asians - Surrey Now-Leader - August 2nd, 2017
- Tampa Florida Stem Cell Clinic - Don't Operate - Regenerate - July 12th, 2017
- Dorothy Jean Kercheval Garrigan - The Messenger (subscription) - July 12th, 2017
- Private clinics are peddling untested stem cell treatments it's unethical and dangerous - Yahoo News UK - July 9th, 2017
- Private clinics' unproven stem cell treatment is unsafe and unethical ... - Business Standard - July 9th, 2017
- Stem Cells Play a Role in Acute Myeloid Leukemia Relapse - Technology Networks - June 30th, 2017
- NBA Star John Salley Partners with Stem Cell Centers of Excellence ... - Market Exclusive - June 30th, 2017
- Making Babies, No Sex Necessary - The Atlantic - June 28th, 2017
- Stem Cell Stem Cell Treatments by Clinic 42 - June 25th, 2017
- Powerful boost for bad skin days - Inquirer.net - June 22nd, 2017
- Here's Why US Stem Cell Inc (OTCMKTS:USRM) Shares Just ... - The Oracle Dispatch - June 21st, 2017
- GE and the Mayo Clinic back software to bring cancer-fighting gene ... - TechCrunch - June 21st, 2017
- Two Notable Announcements in a Week for US Stem Cell Inc ... - Street Register - June 20th, 2017
- Dr. Ruben A. Mesa of Arizona's Mayo Clinic named new director of ... - San Antonio Express-News (subscription) - June 14th, 2017
- Looking Back: June 9, 2017 - Fairbanks Daily News-Miner - June 9th, 2017
- Asymmetrex Director Comments on Positive Attributes of Private ... - PR Web (press release) - June 9th, 2017
- United Veterinary Center Norwalk Offers Stem Cell Therapy to Treat ... - MilTech - June 6th, 2017
- SpaceX to launch heart, bone health experiments to space station - CU Boulder Today - June 2nd, 2017
- Sickle cell cure is real, as this Kansas patient proves - Kansas City Star - May 30th, 2017
- Stem cell agency's response to questions about its performance ... - Capitol Weekly - May 24th, 2017
- US Stem Cell Inc (OTCMKTS:USRM) HEFFX Highlights - Live Trading News - May 24th, 2017